<- Go Home
Evoke Pharma, Inc.
Evoke Pharma, Inc. operates as a specialty pharmaceutical company that focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It offers Gimoti, a metoclopramide nasal spray to treat symptoms associated with acute and recurrent diabetic gastroparesis in adults. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is based in Solana Beach, California.
Market Cap
$22.3M
Volume
730.1K
Cash and Equivalents
$11.6M
EBITDA
N/A
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$14.0M
Profit Margin
97.02%
52 Week High
$10.79
52 Week Low
$1.94
Dividend
N/A
Price / Book Value
5.48
Price / Earnings
-5.69
Price / Tangible Book Value
5.48
Enterprise Value
$15.8M
Enterprise Value / EBITDA
-3.12
Operating Income
-$5.2M
Return on Equity
134.88%
Return on Assets
-21.78
Cash and Short Term Investments
$11.6M
Debt
$5.1M
Equity
$3.4M
Revenue
$14.4M
Unlevered FCF
-$1.3M
Sector
Pharmaceuticals
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium